Abstract:Background: TIM-4, the only TIM protein not expressed on T cells, is found on macrophages and dendritic cells. As an innate immunity-driven local inflammation response, we hypothesized that TIM-4 signaling may play a role in the mechanism of liver IRI. Methods&Results: Unlike in sham controls, the ischemia insult triggered TIM-4 mRNA expression in mouse livers subjected to warm ischemia (90min) and reperfusion (0-24h). Its levels increased progressively, peaking by 6h of reperfusion, and declining at 12-24h. TIM-4 expression correlated with the kinetics of hepatocellular damage (sALT levels), and macrophage infiltration/activation, both peaking at 6h of reperfusion. Indeed, TIM-4 KO or WT (B/6) mice treated with antagonistic TIM-4 mAb (RMT4-53; 0.5 mg i.v. at -1h) were resistant against liver IRI, as shown by sALT levels, hepatic architecture (no edema, vacuolization/necrosis), and Suzuki’s histological score. Unlike in controls, TIM-4 blockade/ablation decreased hepatic CD68+ macrophage sequestration. Although TLR2, TLR4, and TLR9 were all induced in Ig-treated IR-stressed livers, their levels were suppressed in TIM-4 KO groups, along with diminished pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6). To document the function of TIM-4+ macrophages, we have developed a new model of liver IRI in which CD11b-DTR mice were adoptively transferred with syngeneic bone marrow macrophages (BMM; 5×106 cells i.v. at day -1). After DT treatment at day -2 (circulating CD11b <0.2%), CD11b-DTR mice remained uniformly IR-resistant, compared with PBS-controls. Interestingly, unlike WT BMM, which recreated liver IRI after adoptive transfer in CD11b-DTR test mice, infusion of TIM-4-deficient BMM failed to trigger IRI, as shown by diminished sALT levels, well-preserved liver architecture, and decreased Suzuki’s histological score. Of note, consistently heightened TNF-α, IL-1β, and IL-6 levels in CD11b-DTR mice repopulated with TIM-4 proficient (WT) BMM were diminished after infusion of TIM-4 deficient (KO) BMM. Conclusion: This study provides new evidence that: 1) IR-stressed liver macrophages express TIM-4; 2) Disruption of TIM-4 signaling ameliorates liver IRI; and 3) TIM-4 signaling is critically required for macrophage activation in the mechanism of liver IR-damage. Hence, modulation of physiological TIM-4 expression provides the basis for novel therapeutic strategies against organ IRI in transplant recipients.

Fatty Acid Binding Protein-4 (FABP4) is a Hypoxia Inducible Gene That Sensitizes Mice to Liver Ischemia/reperfusion Injury

Hepatic Induction of Fatty Acid Binding Protein 4 Plays a Pathogenic Role in Sepsis in Mice.

Pharmacological Inhibition of Fatty Acid-Binding Protein 4 (FABP4) Protects Against Renal Ischemia-Reperfusion Injury

Fatty Acid-Binding Proteins Aggravate Cerebral Ischemia-Reperfusion Injury in Mice.

FABP4 silencing ameliorates hypoxia reoxygenation injury through the attenuation of endoplasmic reticulum stress-mediated apoptosis by activating PI3K/Akt pathway

Exogenous FABP4 interferes with differentiation, promotes lipolysis and inflammation in adipocytes

Small molecule inhibitors of human adipocyte fatty acid binding protein (FABP4).

Genetic Inhibition of FABP4 Attenuated Endoplasmic Reticulum Stress and Mitochondrial Dysfunction in Rhabdomyolysis-Induced Acute Kidney Injury

FABP4 Inhibitor Alleviates Lipopolysaccharide-Induced HUVEC Injury by Inactivating NF-κB and Activating PPARγ.

Pharmacological Inhibition of Fatty Acid-Binding Protein 4 (FABP4) Protects Against Rhabdomyolysis-Induced Acute Kidney Injury

Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases

FABP4 deficiency ameliorates alcoholic steatohepatitis in mice via inhibition of p53 signaling pathway

Inhibition of Fatty Acid-Binding Protein 4 Attenuated Kidney Fibrosis by Mediating Macrophage-to-Myofibroblast Transition.

FABP4 Is an Indispensable Factor for Regulating Cellular Metabolic Functions of the Human Retinal Choroid

FABP4 Reversed the Regulation of Leptin on Mitochondrial Fatty Acid Oxidation in Mice Adipocytes

Fatty Acid-Binding Protein 4 in Kidney Diseases: from Mechanisms to Clinics.

Inhibition of Adipocyte-Derived FABP4 Reduces Adipocyte Inflammation, Improves Angiogenesis, and Facilitates Wound Healing in Metabolic Dysfunctions

Insulin-like Growth Factor Binding Protein 1 Ameliorates Lipid Accumulation and Inflammation in Nonalcoholic Fatty Liver Disease

Role of Cytosolic Liver Fatty Acid Binding Protein in Hepatocellular Oxidative Stress: Effect of Dexamethasone and Clofibrate Treatment

T-Cell Immunoglobulin and Mucin Domain 4 (Tim-4) Signaling in Innate Immune-Mediated Liver Ischemia-Reperfusion Injury (Iri)

Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration